{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:04:08Z","timestamp":1744344248698,"version":"3.40.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12010-024-05135-7","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T11:56:30Z","timestamp":1734954990000},"page":"2216-2239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In-silico and In-vitro Evaluation of Novel Carboxamide Analogue on the Metastasis of Triple Negative Breast Cancer Cells Utilizing Novel PCPTC-loaded PEGylated-PLGA Nanocarriers"],"prefix":"10.1007","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3058-760X","authenticated-orcid":false,"given":"Ankur","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amka","family":"Nagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Hawthorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohini","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"issue":"3","key":"5135_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41571-018-0134-8","volume":"16","author":"RL Anderson","year":"2019","unstructured":"Anderson, R. L., et al. (2019). A framework for the development of effective anti-metastatic agents. Nature Reviews. Clinical Oncology, 16(3), 185\u2013204. https:\/\/doi.org\/10.1038\/s41571-018-0134-8","journal-title":"Nature Reviews. Clinical Oncology"},{"issue":"7","key":"5135_CR2","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3390\/pharmaceutics11070302","volume":"11","author":"Ketabat","year":"2019","unstructured":"Ketabat, et al. (2019). Controlled drug delivery systems for oral cancer treatment\u2014current status and future perspectives. Pharmaceutics, 11(7), 302. https:\/\/doi.org\/10.3390\/pharmaceutics11070302","journal-title":"Pharmaceutics"},{"key":"5135_CR3","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3389\/fphar.2019.01336","volume":"10","author":"HS Tuli","year":"2019","unstructured":"Tuli, H. S., et al. (2019). Molecular mechanisms of action of genistein in cancer: Recent advances. Frontiers in Pharmacology, 10, 1336. https:\/\/doi.org\/10.3389\/fphar.2019.01336","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"5135_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/17425247.2021.1856073","volume":"18","author":"V Mishra","year":"2021","unstructured":"Mishra, V., Nayak, P., Yadav, N., Singh, M., Tambuwala, M. M., & Aljabali, A. A. A. (2021). Orally administered self-emulsifying drug delivery system in disease management: Advancement and patents. Expert Opinion on Drug Delivery, 18(3), 315\u2013332. https:\/\/doi.org\/10.1080\/17425247.2021.1856073","journal-title":"Expert Opinion on Drug Delivery"},{"key":"5135_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.smaim.2020.04.001","volume":"1","author":"Y Dang","year":"2020","unstructured":"Dang, Y., & Guan, J. (2020). Nanoparticle-based drug delivery systems for cancer therapy. Smart Materials in Medicine, 1, 10\u201319. https:\/\/doi.org\/10.1016\/j.smaim.2020.04.001","journal-title":"Smart Materials in Medicine"},{"key":"5135_CR6","doi-asserted-by":"publisher","unstructured":"Kaur, R., & Khullar, P. (2019). Research progress to improve solubility and drug-releasing curcumin properties with nanoencapsulation. Chemical Nanoscience and Nanotechnology, 241\u2013256. https:\/\/doi.org\/10.1201\/9780429398254-12","DOI":"10.1201\/9780429398254-12"},{"issue":"20","key":"5135_CR7","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.2217\/nnm-2021-0066","volume":"16","author":"A Sharma","year":"2021","unstructured":"Sharma, A., et al. (2021). Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDA-MB231 human breast cancer cells. Nanomedicine, 16(20), 1763\u20131773. https:\/\/doi.org\/10.2217\/nnm-2021-0066","journal-title":"Nanomedicine"},{"issue":"5","key":"5135_CR8","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3892\/mmr.2013.1359","volume":"7","author":"Y-R Liao","year":"2013","unstructured":"Liao, Y.-R., et al. (2013). The novel carboxamide analog ITR-284 induces caspase-dependent apoptotic cell death in human hepatocellular and colorectal cancer cells. Molecular Medicine Reports, 7(5), 1539\u20131544. https:\/\/doi.org\/10.3892\/mmr.2013.1359","journal-title":"Molecular Medicine Reports"},{"issue":"3","key":"5135_CR9","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3892\/or.2017.5374","volume":"37","author":"J-S Yang","year":"2017","unstructured":"Yang, J.-S., Lin, C.-A., Lu, C.-C., Wen, Y.-F., Tsai, F.-J., & Tsai, S.-C. (2017). Carboxamide analog ITR-284 evokes apoptosis and inhibits migration ability in human lung adenocarcinoma A549 cells. Oncology Reports, 37(3), 1786\u20131792. https:\/\/doi.org\/10.3892\/or.2017.5374","journal-title":"Oncology Reports"},{"key":"5135_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fcell.2020.00345","volume":"8","author":"Z Boudhraa","year":"2020","unstructured":"Boudhraa, Z., Carmona, E., Provencher, D., & Mes-Masson, A.-M. (2020). Ran GTPase: A Key Player in Tumor Progression and Metastasis. Frontiers in Cell and Developmental Biology, 8, 345. https:\/\/doi.org\/10.3389\/fcell.2020.00345","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"1\u20132","key":"5135_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijpharm.2017.02.006","volume":"521","author":"YA Haggag","year":"2017","unstructured":"Haggag, Y. A., et al. (2017). Nano-encapsulation of a novel anti-Ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cells. International Journal of Pharmaceutics, 521(1\u20132), 40\u201353. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.02.006","journal-title":"International Journal of Pharmaceutics"},{"issue":"6","key":"5135_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1080\/15384101.2018.1442630","volume":"17","author":"MS Zhang","year":"2018","unstructured":"Zhang, M. S., Furuta, M., Arnaoutov, A., & Dasso, M. (2018). RCC1 regulates inner centromeric composition in a Ran-independent fashion. Cell Cycle, 17(6), 739\u2013748. https:\/\/doi.org\/10.1080\/15384101.2018.1442630","journal-title":"Cell Cycle"},{"issue":"6","key":"5135_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41419-018-0584-z","volume":"9","author":"L Qiao","year":"2018","unstructured":"Qiao, L., et al. (2018). Regulator of chromatin condensation 1 abrogates the G1 cell cycle checkpoint via Cdk1 in human papillomavirus E7-expressing epithelium and cervical cancer cells. Cell Death & Disease, 9(6), 583. https:\/\/doi.org\/10.1038\/s41419-018-0584-z","journal-title":"Cell Death & Disease"},{"issue":"1","key":"5135_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s43556-020-00011-2","volume":"1","author":"J Zhou","year":"2020","unstructured":"Zhou, J., et al. (2020). GEF-independent Ran activation shifts a fraction of the protein to the cytoplasm and promotes cell proliferation. Molecular Biomedicine, 1(1), 18. https:\/\/doi.org\/10.1186\/s43556-020-00011-2","journal-title":"Molecular Biomedicine"},{"issue":"13","key":"5135_CR15","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F., et al. (2004). UCSF Chimera?A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605\u20131612. https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"Journal of Computational Chemistry"},{"key":"5135_CR16","doi-asserted-by":"crossref","unstructured":"Sander, T. (2001) OSIRIS Property Explorer. Organic Chemistry Portal. https:\/\/www.organic-chemistry.org\/prog\/peo","DOI":"10.1002\/1099-0690(200110)2001:20<3771::AID-EJOC3771>3.0.CO;2-0"},{"issue":"1","key":"5135_CR17","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Science and Reports, 7(1), 42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Science and Reports"},{"issue":"11","key":"5135_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4236\/abb.2019.1011030","volume":"10","author":"B Sarkar","year":"2019","unstructured":"Sarkar, B., Islam, S. S., Ullah, Md. A., Hossain, S., Prottoy, Md. N. I., Araf, Y., & Taniya, M. A. (2019). Computational Assessment and Pharmacological Property Breakdown of Eight Patented and Candidate Drugs against Four Intended Targets in Alzheimer\u2019s Disease. Advances in Bioscience and Biotechnology, 10(11), 405\u2013430. https:\/\/doi.org\/10.4236\/abb.2019.1011030","journal-title":"Advances in Bioscience and Biotechnology"},{"key":"5135_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2023.2208214","volume":"42","author":"M Chouhan","year":"2023","unstructured":"Chouhan, M., et al. (2023). Inhibition of Mycobacterium tuberculosis resuscitation-promoting factor B (RpfB) by microbially derived natural compounds: A computational study. Journal of Biomolecular Structure and Dynamics, 42, 1\u201312. https:\/\/doi.org\/10.1080\/07391102.2023.2208214","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"key":"5135_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejphar.2015.04.014","volume":"760","author":"T Mahaddalkar","year":"2015","unstructured":"Mahaddalkar, T., Suri, C., Naik, P. K., & Lopus, M. (2015). Biochemical characterization and molecular dynamic simulation of \u03b2-sitosterol as a tubulin-binding anticancer agent. European Journal of Pharmacology, 760, 154\u2013162. https:\/\/doi.org\/10.1016\/j.ejphar.2015.04.014","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"5135_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11095-018-2555-6","volume":"36","author":"A Sharma","year":"2019","unstructured":"Sharma, A., McCarron, P., Matchett, K., Hawthorne, S., & El-Tanani, M. (2019). Anti-invasive and anti-proliferative effects of shrna-loaded poly(Lactide-Co-Glycolide) nanoparticles following RAN silencing in MDA-MB231 breast cancer cells. Pharmaceutical Research, 36(2), 26. https:\/\/doi.org\/10.1007\/s11095-018-2555-6","journal-title":"Pharmaceutical Research"},{"key":"5135_CR22","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.2147\/IJN.S84326","volume":"10","author":"L Zhou","year":"2015","unstructured":"Zhou, L., et al. (2015). Codelivery of SH-aspirin and curcumin by mPEG-PLGA nanoparticles enhanced antitumor activity by inducing mitochondrial apoptosis. International Journal of Nanomedicine, 10, 5205\u20135218. https:\/\/doi.org\/10.2147\/IJN.S84326","journal-title":"International Journal of Nanomedicine"},{"key":"5135_CR23","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.2147\/IJN.S24552","volume":"6","author":"S Mura","year":"2011","unstructured":"Mura, S., Hillaireau, H., Nicolas, J., Le Droumaguet, B., Gueutin, C., Zanna, S., Tsapis, N., & Fattal, E. (2011). Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. International Journal of Nanomedicine, 6, 2591\u20132605. https:\/\/doi.org\/10.2147\/IJN.S24552","journal-title":"International Journal of Nanomedicine"},{"key":"5135_CR24","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.2147\/DDDT.S79812","volume":"9","author":"AH Hassan","year":"2015","unstructured":"Hassan, A. H., Hosny, K. M., Murshid, Z. A., Alhadlaq, A., Alyamani, A., & Naguib, G. (2015). Depot injectable biodegradable nanoparticles loaded with recombinant human bone morphogenetic protein-2: preparation, characterization, and in vivo evaluation. Drug Design, Development and Therapy, 9, 3599\u20133606. https:\/\/doi.org\/10.2147\/DDDT.S79812","journal-title":"Drug Design, Development and Therapy"},{"key":"5135_CR25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2147\/IJN.S73508","volume":"10","author":"SP Lamichhane","year":"2015","unstructured":"Lamichhane, S. P., Arya, N., Ojha, N., Kohler, E., & Shastri, V. P. (2015). Glycosaminoglycan-functionalized poly-lactide-co-glycolide nanoparticles: synthesis, characterization, cytocompatibility, and cellular uptake. International Journal of Nanomedicine, 10, 775\u2013789. https:\/\/doi.org\/10.2147\/IJN.S73508","journal-title":"International Journal of Nanomedicine"},{"key":"5135_CR26","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.2147\/IJN.S77498","volume":"10","author":"A Lopalco","year":"2015","unstructured":"Lopalco, A., Ali, H., Denora, N., & Rytting, E. (2015). Oxcarbazepine-loaded polymeric nanoparticles: development and permeability studies across in vitro models of the blood-brain barrier and human placental trophoblast. International Journal of Nanomedicine, 10, 1985\u20131996. https:\/\/doi.org\/10.2147\/IJN.S77498","journal-title":"International Journal of Nanomedicine"},{"issue":"5","key":"5135_CR27","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/cnr2.1271","volume":"3","author":"A Sharma","year":"2020","unstructured":"Sharma, A., et al. (2020). Nanoparticulate RNA delivery systems in cancer. Cancer Reports, 3(5), 1271. https:\/\/doi.org\/10.1002\/cnr2.1271","journal-title":"Cancer Reports"},{"issue":"1","key":"5135_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijpharm.2017.08.118","volume":"532","author":"C Rodrigues De Azevedo","year":"2017","unstructured":"Rodrigues De Azevedo, C., et al. (2017). Modeling of the burst release from PLGA micro- and nanoparticles as function of physicochemical parameters and formulation characteristics. International Journal of Pharmaceutics, 532(1), 229\u2013240. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.08.118","journal-title":"International Journal of Pharmaceutics"},{"issue":"2","key":"5135_CR29","doi-asserted-by":"publisher","first-page":"e03451","DOI":"10.1016\/j.heliyon.2020.e03451","volume":"6","author":"L PourtalebiJahromi","year":"2020","unstructured":"PourtalebiJahromi, L., Ghazali, M., Ashrafi, H., & Azadi, A. (2020). A comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles. Heliyon, 6(2), e03451. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03451","journal-title":"Heliyon"},{"issue":"3","key":"5135_CR30","first-page":"819","volume":"13","author":"MN Koopaei","year":"2014","unstructured":"Koopaei, M. N., et al. (2014). Docetaxel loaded PEG-PLGA nanoparticles: Optimized drug loading, in-vitro cytotoxicity and in-vivo antitumor effect. Iranian journal of pharmaceutical research: IJPR, 13(3), 819.","journal-title":"Iranian journal of pharmaceutical research: IJPR"},{"issue":"3","key":"5135_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1124\/mol.114.096941","volume":"87","author":"A Pulkoski-Gross","year":"2015","unstructured":"Pulkoski-Gross, A., et al. (2015). Repurposing the Antipsychotic Trifluoperazine as an Antimetastasis Agent. Molecular Pharmacology, 87(3), 501\u2013512. https:\/\/doi.org\/10.1124\/mol.114.096941","journal-title":"Molecular Pharmacology"},{"issue":"19","key":"5135_CR32","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1039\/D1TB00397F","volume":"9","author":"S Yang","year":"2021","unstructured":"Yang, S., Sun, I.-C., Hwang, H. S., Shim, M. K., Yoon, H. Y., & Kim, K. (2021). Rediscovery of nanoparticle-based therapeutics: Boosting immunogenic cell death for potential application in cancer immunotherapy. Journal of Materials Chemistry B, 9(19), 3983\u20134001. https:\/\/doi.org\/10.1039\/D1TB00397F","journal-title":"Journal of Materials Chemistry B"},{"issue":"12","key":"5135_CR33","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/pharmaceutics12121165","volume":"12","author":"Y Choi","year":"2020","unstructured":"Choi, Y., et al. (2020). Doxorubicin-loaded PLGA nanoparticles for cancer therapy: Molecular weight effect of PLGA in doxorubicin release for controlling immunogenic cell death. Pharmaceutics, 12(12), 1165. https:\/\/doi.org\/10.3390\/pharmaceutics12121165","journal-title":"Pharmaceutics"},{"issue":"2","key":"5135_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.nano.2016.08.001","volume":"13","author":"Z Wang","year":"2017","unstructured":"Wang, Z., et al. (2017). \u201cPoly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells. Nanomedicine: Nanotechnology Biology and Medicine, 13(2), 641\u2013657. https:\/\/doi.org\/10.1016\/j.nano.2016.08.001","journal-title":"Nanomedicine: Nanotechnology Biology and Medicine"},{"key":"5135_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.558741","volume":"11","author":"J Shi","year":"2020","unstructured":"Shi, J., et al. (2020). Celastrol: A review of useful strategies overcoming its limitation in anticancer application. Frontiers in Pharmacology, 11, 558741. https:\/\/doi.org\/10.3389\/fphar.2020.558741","journal-title":"Frontiers in Pharmacology"},{"issue":"57","key":"5135_CR36","doi-asserted-by":"publisher","first-page":"34517","DOI":"10.1039\/D0RA04231E","volume":"10","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y., et al. (2020). Improved therapeutic efficacy of quercetin-loaded polymeric nanoparticles on triple-negative breast cancer by inhibiting uPA. RSC Advances, 10(57), 34517\u201334526. https:\/\/doi.org\/10.1039\/D0RA04231E","journal-title":"RSC Advances"},{"issue":"11","key":"5135_CR37","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1080\/17425247.2020.1813714","volume":"17","author":"Y Haggag","year":"2020","unstructured":"Haggag, Y., et al. (2020). Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells. Expert Opinion on Drug Delivery, 17(11), 1655\u20131669. https:\/\/doi.org\/10.1080\/17425247.2020.1813714","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"2","key":"5135_CR38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/cancers11020222","volume":"11","author":"Y Haggag","year":"2019","unstructured":"Haggag, Y., et al. (2019). Novel Ran-RCC1 inhibitory peptide-loaded nanoparticles have anti-cancer efficacy In Vitro and In Vivo. Cancers, 11(2), 222. https:\/\/doi.org\/10.3390\/cancers11020222","journal-title":"Cancers"},{"issue":"1","key":"5135_CR39","first-page":"157","volume":"18","author":"C Sheng","year":"2018","unstructured":"Sheng, C., et al. (2018). Knockdown of Ran GTPase expression inhibits the proliferation and migration of breast cancer cells. Molecular Medicine Reports, 18(1), 157\u2013168.","journal-title":"Molecular Medicine Reports"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-024-05135-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-024-05135-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-024-05135-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T08:14:17Z","timestamp":1744272857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-024-05135-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["5135"],"URL":"https:\/\/doi.org\/10.1007\/s12010-024-05135-7","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"type":"print","value":"0273-2289"},{"type":"electronic","value":"1559-0291"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"This research does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Free.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}